CLINICAL_TRIALS
trial_result
· 2016-06-28
Clinical Trial Update: Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 (P07063) [Phase 3]
Summary
Phase 3 trial update on safety and efficacy of boceprevir in Asia Pacific participants with chronic hepatitis C genotype 1 completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2016-06-28